|drug1639||In-person instruction Wiki||1.00|
|D003141||Communicable Diseases NIH||0.07|
There is one clinical trial.
Whether university teaching on campus with infection control measures in place is associated with higher risk of COVID-19 than online instruction, is unknown. The investigators will assess this by conducting repeated surveys among students at universities and university colleges in Norway, where some instruction is given in-person, and some is provided online (hybrid model). The investigators will ask about the students' COVID-19 status, and how much in-person and online instruction the students are getting. The investigators will estimate the association between in-person instruction and COVID-19-risk using multivariate regression, controlling for likely confounders. The investigators will also assess whether type of instruction is associated with how satisfied the students are with the instruction the students are offered, their quality of life, and learning outcomes.
Description: Self-reported positive test resultsMeasure: COVID-19 incidence Time: Through study completion, i.e. 4 months.
Description: Self-reported ("Overall, how satisfied are you with life right now?")Measure: Quality of life Time: Through study completion, i.e. 4 months.
Description: Self-reported ("Overall, how satisfied have you been with the teaching you have received in the past 14 days?")Measure: Satisfaction with teaching Time: Through study completion, i.e. 4 months.
Description: Self-reportedMeasure: COVID-19 testing incidence Time: Through study completion, i.e. 4 months.
Description: Exam results from Common Student SystemMeasure: Learning outcome Time: End of term, December 2020.
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports